Results 1 to 10 of about 99,805 (324)

What is polypharmacy? A systematic review of definitions [PDF]

BMC Geriatrics, 2017
Background Multimorbidity and the associated use of multiple medicines (polypharmacy), is common in the older population. Despite this, there is no consensus definition for polypharmacy.
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E. Caughey   +3 more
doaj   +2 more sources

Polypharmacy and healthcare expenditures among older adults in the United States: a propensity score-matched study [PDF]

BMC Geriatrics
Background Polypharmacy is associated with increased risk of adverse events and may increase healthcare expenditures. However, there is a lack of study using nationally representative data to assess additional healthcare costs associated with ...
Shaoxi Pan, Shanshan Li, Yin Shi, Qi Kang, Shaoxiang Jiang, Gordon G. Liu, Hongyan Wu, Beini Lyu   +7 more
doaj   +2 more sources

Polypharmacy [PDF]

JAMA, 2017
na
Onder, Graziano, Marengoni, Alessandra
  +13 more sources

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study

Exploratory Research in Clinical and Social Pharmacy, 2021
Background: Although multiple medications are often utilized to achieve optimal treatment outcomes, polypharmacy (use of five or more medications) among older population is associated with several detrimental effects.
Kailash Thapaliya, Melissa L. Harris, Julie E. Byles   +2 more
doaj   +1 more source

Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis

BMC Geriatrics, 2022
Introduction Polypharmacy is commonly associated with adverse health outcomes. There are currently no meta-analyses of the prevalence of polypharmacy or factors associated with polypharmacy.
Mahin Delara, Lauren Murray, Behnaz Jafari, Anees Bahji, Zahra Goodarzi, Julia Kirkham, Zia Chowdhury, Dallas P. Seitz   +7 more
doaj   +1 more source

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019

Frontiers in Pharmacology, 2022
Background: Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010–2019 ...
Ho Jin Cho, Jungmi Chae, Sang-Heon Yoon, Dong-Sook Kim   +3 more
doaj   +1 more source

Defining polypharmacy: in search of a more comprehensive determination method applied in a tertiary psychiatric hospital

Therapeutic Advances in Psychopharmacology, 2021
Aims: This cross-sectional pharmacoepidemiologic study examined the prevalence of polypharmacy and psychotropic polypharmacy among inpatients in a tertiary psychiatric hospital in Belgium.
Jeroen Govaerts, Julie Boeyckens, Astrid Lammens, Annelies Gilis, Filip Bouckaert, Marc De Hert, Jan De Lepeleire, Brendon Stubbs, Franciska Desplenter   +8 more
doaj   +1 more source

Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.

PLoS ONE, 2021
Background/objectivesWith an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications.
Eric H Young, Samantha Pan, Alex G Yap, Kelly R Reveles, Kajal Bhakta   +4 more
doaj   +1 more source

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study

Frontiers in Pharmacology, 2020
AimPolypharmacy is becoming a global health problem. The aims of this study were to evaluate the temporal trends in the prevalence of polypharmacy in Sweden and to explore polypharmacy disparities by age, gender, education, and immigration status ...
Naiqi Zhang, Jan Sundquist, Jan Sundquist, Jan Sundquist, Kristina Sundquist, Kristina Sundquist, Kristina Sundquist, Jianguang Ji   +7 more
doaj   +1 more source

Antipsychotic Polypharmacy

Focus, 2020
Physicians who treat patients with schizophrenia frequently encounter complex clinical situations not fully addressed by published treatment guidelines. Some of these situations lead to antipsychotic polypharmacy, often prescribed when clinical and social obstacles prevent access to clozapine and patients have had suboptimal responses to nonclozapine ...
Adriana, Foster, Jordanne, King
openaire   +3 more sources